JMI Laboratories

North Liberty, United States Founded: 2000 • Age: 26 yrs Acquired By Element Materials Technology
Microbial strains are developed by JMI Laboratories as a CDMO.

About JMI Laboratories

JMI Laboratories is a Healthcare company based in North Liberty (United States) founded in 2000, and was acquired by Element Materials Technology in November 2021. Microbial strains are developed by JMI Laboratories as a CDMO. Its chief executive, as recorded, is Andrew Fuhrmeister. JMI Laboratories offers products and services including Antimicrobial Surveillance, Drug Development, Molecular Studies, Clinical Trial Support, and Microbiome Investigations. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Microbial Strains.

Company details

JMI Laboratories was established in 2000 and is based in North Liberty, United States. Focus is placed on contract development and manufacturing services within the biotechnology sector, particularly the engineering and optimization of microbial strains for industrial applications. Operations involve strain selection, genetic modification, and scale-up processes to support pharmaceutical and bioprocessing needs. Leadership is held by CEO Andrew Fuhrmeister, overseeing research and production activities.

  • Headquarters North Liberty, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website jmilabs.com
  • Social LinkedIn X
  • Acquired by Element Materials Technology (Nov 2021)
Key Metrics

Products & Services of JMI Laboratories

JMI Laboratories offers a comprehensive portfolio of products and services, including Antimicrobial Surveillance, Drug Development, Molecular Studies, Clinical Trial Support, and Microbiome Investigations.

Antimicrobial Surveillance
Surveillance Services

Conducts studies for new drug applications and post-marketing commitments.

Drug Development
Laboratory Services

Supports development of new investigational compounds through testing.

Molecular Studies
Research Services

Provides characterization of isolates including resistance and virulence genes.

Clinical Trial Support
Trial Services

Offers GCLP support for bacterial and fungal clinical trials phases.

Microbiome Investigations
Genetic Services

Delivers laboratory support for microbiome genetic studies.

Medical Writing
Writing Services

Assists in disseminating study results to scientific communities.

Investors in JMI Laboratories

JMI Laboratories has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Element Materials Technology.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Materials and product testing, inspection, and certification services are provided.
1827element.comLondon, United Kingdom
Premium access

Investor details for JMI Laboratories

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of JMI Laboratories

16 people are tracked at JMI Laboratories (6 in leadership, 1 in board & advisors, 9 in team).

NameRoleGroup
Andrew Fuhrmeister
CEOLeadership
Mariana Castanheira
Chief Scientific OfficerLeadership
Helio S. Sader
Director, SurveillanceLeadership
Leonard Duncan
Associate Director, Antimicrobial DevelopmentLeadership
Rodrigo E. Mendes
Director, Molecular & MicrobiologyLeadership
Robert Flamm
Senior Director, Antimicrobial DevelopmentLeadership
Ronald N. Jones
Founder & ChairmanBoard & advisors
Holly Huynh
Microbiologist IIITeam
Jessica Ewald
Lead Bioinformatics ScientistTeam
Gina Bartleson
Research ScientistTeam
Abby Klauer
MicrobiologistTeam
Elena Neuhaus
MicrobiologistTeam
Joshua Maher
Principal ScientistTeam
Maura Karr
Bioinformatics ScientistTeam
Shannin Zevian
Microbiologist IITeam
Gauri Deshpande
Molecular ScientistTeam
Premium access

Complete people profiles for JMI Laboratories

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of JMI Laboratories

2 dated milestones of JMI Laboratories across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded JMI Laboratories is founded.
  2. Exit Acquired by Element Materials Technology.

Web traffic of JMI Laboratories

The website of JMI Laboratories (jmilabs.com) receives about 3K visits a month.

  • Monthly visits
    3K

    ▼ 27.5% vs previous month

Similar websites

Websites whose visitors overlap most with JMI Laboratories. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ihma.com
100%
3.7K#5,352,458View details

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as JMI Laboratories (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Jmi Laboratories

Element Expands Life Sciences Testing Business
Contractpharma β€’ 4 years ago
Element Acquires JMI Laboratories
Biopharminternational β€’ 5 years ago
Premium access

Complete news archive for JMI Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about JMI Laboratories

JMI Laboratories was founded in 2000.

JMI Laboratories is headquartered in North Liberty, United States. It is registered at North Liberty, Iowa, United States.

Andrew Fuhrmeister is the CEO of JMI Laboratories, as recorded in our data.

JMI Laboratories was established in 2000 and is based in North Liberty, United States. Focus is placed on contract development and manufacturing services within the biotechnology sector, particularly the engineering and optimization of microbial strains for industrial applications. Operations involve strain selection, genetic modification, and scale-up processes to support pharmaceutical and bioprocessing needs. Leadership is held by CEO Andrew Fuhrmeister, overseeing research and production activities.

JMI Laboratories offers Antimicrobial Surveillance, Drug Development, Molecular Studies, Clinical Trial Support, and 2 more products and services.

JMI Laboratories has 1 investor. Key investors include Element Materials Technology.

Yes. JMI Laboratories was acquired by Element Materials Technology in November 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available